# Genomic Imprinting Testing for Diagnosis of Bladder Cancer

> **NCT03563443** · — · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Bladder Cancer
- Urine Marking
- Diagnoses Disease

## Interventions

- **DIAGNOSTIC_TEST:** Genomic Imprinting Testing

## Key facts

- **NCT ID:** NCT03563443
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-15
- **Primary completion:** 2018-12-15
- **Final completion:** 2019-12-15
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563443, "Genomic Imprinting Testing for Diagnosis of Bladder Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03563443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*